Search clinical trials for: Growth Hormone treatment

Total 117542 results

National Cancer Institute (NCI)
NRG Oncology

Completed

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditions

United States
Merck Sharp & Dohme LLC

Terminated

A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)

Multiple Myeloma
Retina Macula Institute
Allergan

Completed

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy

United States
ImmunityBio, Inc.

Withdrawn

QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

Non-small Cell Lung Cancer
Yale University
Novartis; Genentech, Inc.

Terminated

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer

Breast Cancer | Hormone-Sensitive Breast Cancer

United States
Fondazione EMN Italy Onlus

Terminated

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment (PO-3887)

Multiple Myeloma

Italy
Hospital Universitario de Canarias

Completed

Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema (ALBA)

Diabetic Macular Edema

Spain
University of Erlangen-Nürnberg Medical School

Completed

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin (ISS)

Idiopathic Short Stature

Germany
University of Aarhus

Unknown

Acromegaly - Before and After Treatment

Cardiovascular Diseases | Bone Diseases | Sleep Apnea | Acromegaly | Growth Hormone Treatment

Denmark
Baylor College of Medicine
Eli Lilly and Company; TAP Pharmaceutical Products Inc.

Terminated

Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism

Hypothyroidism

United States
He Eye Hospital

Unknown

Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

Central Retinal Vein Occlusion

China
He Eye Hospital

Unknown

Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

Branch Retinal Vein Occlusion

China
He Eye Hospital

Unknown

Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.

Macular Edema

China
Peking University Shenzhen Hospital
Shanghai Shyndec Pharmaceutical Co., Ltd.

Completed

Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

China
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (CONSTELLATION)

Diabetes | Macular Degeneration | Macular Edema

France
Novo Nordisk A/S

Completed

Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)

Growth Hormone Deficiency in Children | Growth Disorder

United States, United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
Novartis

Completed

Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study (RaDiVit)

Diabetic Retinopathy | Retinal Neovascularisation

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
Novartis

Completed

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation (LUCIDATE)

Diabetic Retinopathy

United Kingdom
Ipsen

Terminated

Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency

Growth Disorders

France
Bayer

Terminated

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Breast Neoplasms

Spain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
Medstar Health Research Institute
Pfizer

Completed

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer (IIT Sutent)

Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Follicular Thyroid Cancer

United States
University of California, San Francisco

Withdrawn

Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema

Diabetic Macular Edema

United States
Cyprus University of Technology

Unknown

Education Intervention in Patients With Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. (EGFR)

Breast Cancer | Head and Neck Cancer | Lung Cancer | Colon Cancer | Pancreas Cancer | Consent Form

Cyprus
Ipsen

Completed

Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency

Growth Disorders | Insulin-Like Growth Factor-1 Deficiency

United States
Translational Research Center for Medical Innovation...
Hiroshima Prefectural Hospital; National Hospital Organization Shikoku Cancer...

Completed

Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer (BeTRI)

Metastatic Colorectal Cancer

Japan
Göteborg University

Completed

Growth Hormone in Ischemic Heart Failure

Heart Failure, Systolic | Ischemic Heart Disease Chronic
Riyadh Fertility and Reproductive Health center

Unknown

Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

Infertility, Female

Egypt
Celgene
Multiple Myeloma Research Consortium

Completed

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
NCIC Clinical Trials Group

Completed

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Canada, United States
Federation Francophone de Cancerologie Digestive

Completed

G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

Colorectal Cancer
University of Aarhus

Completed

Lipolytic Effects of GH in Human Subjects in Vivo

Metabolic Diseases | Growth Hormone Treatment

Denmark
First Affiliated Hospital of Wenzhou Medical University
Second Affiliated Hospital of Wenzhou Medical University; Wenzhou Central Hospital

Unknown

The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19

COVID-19 Thalidomide
Center for Human Reproduction

Unknown

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

Female Infertility Due to Diminished Ovarian Reserve

United States
Takeda

Withdrawn

A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation (IDEALL)

Multiple Myeloma

Brazil
The University of Texas Medical Branch, Galveston
National Institutes of Health (NIH); National Institute of General Medical... and other collaborators

Terminated

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

Burns

United States
Ipsen

Completed

Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly

Acromegaly

Germany
Prof. Dr. Antonia M. Joussen
Charite University, Berlin, Germany

Terminated

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab (DORO)

Macular Edema, Cystoid | Visual Acuity Reduced Transiently

Germany
Pfizer

Completed

A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients

Growth Hormone Deficiency

Sweden
Celgene

Completed

Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma (OPTIMUM)

Multiple Myeloma

India, Philippines, France, Portugal, Poland, South Africa, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Serbia, Slovakia, United Kingdom
Dana-Farber Cancer Institute
Celgene Corporation

Terminated

A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
NYU Langone Health
Genentech, Inc.; University of New Mexico Cancer Center

Completed

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Ovarian Cancer

United States
University of Aarhus
Aarhus University Hospital

Unknown

Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle

Growth Hormone Deficiency | Growth Hormone Treatment

Denmark
Novo Nordisk A/S

Completed

Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy

Growth Hormone Deficiency in Children

Germany
Royal Marsden NHS Foundation Trust
Celgene Corporation

Active, not recruiting

Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND) (LEGEND)

Diffuse Large B-Cell Lymphoma

United Kingdom
Medical College of Wisconsin
University of Wisconsin, Milwaukee

Completed

Photobiomodulation for the Treatment of Diabetic Macular Edema (PTDME)

Diabetic Retinopathy

United States
Arman Mashayekhi
Allergan

Terminated

Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Macular Edema | Uveal Melanoma | Radiation Retinopathy | Cystoid Macular Edema | Radiation Maculopathy

United States
AbbVie
Genentech, Inc.; Celgene Corporation

Withdrawn

A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy

Multiple Myeloma

United States, Australia, Canada, Spain
The First Hospital of Jilin University

Unknown

Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma

Multiple Myeloma in Relapse

China
Sandoz

Terminated

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age (SGA)

Short Children Born Small for Gestational Age (SGA)

Czechia, Germany, Hungary, Poland, Georgia, Romania
Johannes Gutenberg University Mainz
Pierre Fabre Pharma GmbH

Completed

Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer (VinoMetro)

Metastatic Breast Cancer

Germany

3

Subscribe